Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3876
Martin Midstream Partners
MMLP
$92.1M
| $291K | ﹤0.01% |
14,556
-6,160
| -30% | -$116K |
|
|
RDUS
3877
DELISTED
Radius Recycling
RDUS
| $291K | ﹤0.01% |
14,127
+9,874
| +232% | +$231K |
|
3878
Invesco S&P 500 Pure Growth ETF
RPG
$2.1B
| $291K | ﹤0.01% |
16,250
| – | – |
|
|
DENN
3879
DELISTED
Denny's
DENN
| $290K | ﹤0.01% |
23,410
-85,188
| -78% | -$1.06M |
|
3880
Orthofix Medical
OFIX
$421M
| $290K | ﹤0.01% |
7,582
-3,919
| -34% | -$145K |
|
|
AAIC
3881
DELISTED
Arlington Asset Investment Corp.
AAIC
| $290K | ﹤0.01% |
20,435
+19,520
| +2,133% | +$287K |
|
|
XENT
3882
DELISTED
Intersect ENT, Inc
XENT
| $290K | ﹤0.01% |
16,923
-283,380
| -94% | -$3.97M |
|
|
BOBE
3883
DELISTED
Bob Evans Farms, Inc.
BOBE
| $290K | ﹤0.01% |
4,456
-1,923
| -30% | -$109K |
|
3884
CALL
ProShares UltraShort Silver
ZSL
$55.2M
| $289K | ﹤0.01% |
63
-1
| -2% | -$5.1K |
|
|
PZE
3885
DELISTED
Petrobras Argentina S A
PZE
| $289K | ﹤0.01% |
26,200
-94
| -0.4% | -$881 |
|
|
EE
3886
DELISTED
El Paso Electric Company
EE
| $289K | ﹤0.01% |
5,730
+1,722
| +43% | +$81.6K |
|
3887
PUT
Boston Scientific
BSX
$69.2B
| $288K | ﹤0.01% |
11,600
-70,500
| -86% | -$1.71M |
|
3888
Global Partners
GLP
$1.67B
| $288K | ﹤0.01% |
14,777
-8,214
| -36% | -$163K |
|
3889
Hovnanian Enterprises
HOV
$808M
| $288K | ﹤0.01% |
5,077
+3,332
| +191% | +$197K |
|
3890
CALL
IAMGOLD
IAG
$9.18B
| $288K | ﹤0.01% |
72,000
-2,614,400
| -97% | -$11.1M |
|
3891
CALL
S&P Global
SPGI
$121B
| $288K | ﹤0.01% |
2,200
-2,500
| -53% | -$311K |
|
|
VRE
3892
DELISTED
Veris Residential
VRE
| $288K | ﹤0.01% |
10,721
+1,427
| +15% | +$40K |
|
|
EPZM
3893
DELISTED
Epizyme, Inc
EPZM
| $287K | ﹤0.01% |
16,677
+12,970
| +350% | +$173K |
|
|
CHL
3894
CALL
DELISTED
China Mobile Limited
CHL
| $287K | ﹤0.01% |
5,200
-8,400
| -62% | -$469K |
|
3895
Liberty Media Series C
FWONK
$24.1B
| $286K | ﹤0.01% |
8,701
+1,669
| +24% | +$51.5K |
|
3896
MillerKnoll
MLKN
$1.63B
| $286K | ﹤0.01% |
9,056
-1,379
| -13% | -$42.7K |
|
3897
PUT
Toronto Dominion Bank
TD
$200B
| $286K | ﹤0.01% |
5,700
-1,700
| -23% | -$86.9K |
|
|
NPTN
3898
DELISTED
NEOPHOTONICS CORP
NPTN
| $286K | ﹤0.01% |
31,819
-24,784
| -44% | -$258K |
|
3899
Churchill Downs
CHDN
$6.02B
| $285K | ﹤0.01% |
10,740
+6,624
| +161% | +$165K |
|
|
ODP
3900
PUT
DELISTED
ODP
ODP
| $285K | ﹤0.01% |
6,120
-21,700
| -78% | -$982K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.